A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)
Clinical trial NCT00628342 · COMPLETED
Trial details
- NCT number
- NCT00628342
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-04-01
- Primary completion
- 2003-08-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.